NCT02089828

Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia

Randomized Control Trial on Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Shanghai Zhongshan Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

To compare the efficacy and cost-effectiveness between purified CD34+ cells and peripheral blood mononuclear cells in treatment of critical limb ischemia

Conditions

• Thromboangiitis Obliterans
• Arteritis
• Peripheral Arterial Disease

Interventions

Type	Name	Description
OTHER	autologous purified CD34+ cells
OTHER	autologous peripheral blood mononuclear cells

Timeline

• Start date: 2014-03-01
• Primary completion: 2017-12-01
• Completion: 2018-12-01
• First posted: 2014-03-18
• Last updated: 2016-04-19

Locations

1 site across 1 country: China